
|Videos|December 5, 2021
Dr. Garraway summarizes SUO session on early detection and treatment of prostate cancer
Author(s)Urology Times staff
“It’s really important to look at the pathology we’ve learned before considering these patients for active surveillance treatment,” says Isla Garraway, MD, PhD.
Advertisement
In this video, Isla Garraway, MD, PhD, discusses key points of the session on early detection and treatment of prostate cancer that was presented at the 2021 Society of Urologic Oncology Annual Meeting. Garraway is an associate professor and director of research in the department of urology, and a member of the Jonsson Comprehensive Cancer Center and Broad Center for Regenerative Medicine at the UCLA School of Medicine in Los Angeles, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
Alternative BCG strains may help address ongoing supply challenges in NMIBC
3
Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA
4
Doublet or triplet? Urologists weighs in on mCSPC options
5






